ADPT Return on Tangible Equity | ADAPTIVE BIOTECHNOLOGIES CORPORATION

ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Return on Tangible Equity

2026-06-30: Return Tang Equity -276.93%.
2026-03-31: Return Tang Equity -51.72%.
2025-12-31: Return Tang Equity -60.65%.
2025-09-30: Return Tang Equity -95.56%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-276.93%
2026-03-31	-51.72%
2025-12-31	-60.65%
2025-09-30	-95.56%
2025-06-30	-208.43%
2025-03-31	-207.23%
2024-12-31	-198.59%
2024-09-30	-193.41%
2024-06-30	-180.37%
2024-03-31	-142.20%
2023-12-31	-122.22%
2023-09-30	-82.60%
2023-06-30	-70.43%
2023-03-31	-65.35%
2022-12-31	-59.16%
2022-09-30	-61.25%
2022-06-30	-59.27%
2022-03-31	-53.83%
2021-12-31	-43.50%
2021-09-30	-36.37%
2021-06-30	-30.32%
2021-03-31	-26.05%
2020-12-31	-23.81%
2020-09-30	-18.94%
2020-06-30	-24.88%
2020-03-31	-19.38%
2019-12-31	-15.59%
2019-09-30	-13.48%
2019-06-30	13.36%
2019-03-31	12.91%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-60.65%
2024-12-31	-198.59%
2023-12-31	-122.22%
2022-12-31	-59.16%
2021-12-31	-43.50%
2020-12-31	-23.81%
2019-12-31	-15.59%
2018-12-31	11.89%
2017-12-31	19.07%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)	United States	$4.897B	-6.51
CRISPR Therapeutics AG (CRSP)		$5.390B	-11.68
Relay Therapeutics, Inc. (RLAY)	United States	$3.884B	-14.30
Scholar Rock Holding Corp (SRRK)	United States	$5.920B	-16.37
CG Oncology, Inc. (CGON)	United States	$6.095B	-27.95
Tarsus Pharmaceuticals, Inc. (TARS)	United States	$3.329B	-58.60
Denali Therapeutics Inc. (DNLI)	United States	$3.274B	-8.04
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78
Greenland Mines Ltd (GRML)	United States	$2.362B